Literature DB >> 22541053

TaqIA polymorphism in dopamine D2 receptor gene complicates weight maintenance in younger obese patients.

Julia K Winkler1, Annika Woehning, Jobst-Hendrik Schultz, Maik Brune, Nigel Beaton, Tenagne Delessa Challa, Stella Minkova, Eva Roeder, Peter P Nawroth, Hans-Christoph Friederich, Christian Wolfrum, Gottfried Rudofsky.   

Abstract

OBJECTIVE: The A1 allele of the TaqIA polymorphism in the dopamine D2 receptor gene (rs1800497) has been associated with obesity. However, the effect of the polymorphism on the success in weight loss and/or weight maintenance during weight-loss programs has not been evaluated thus far.
METHODS: The rs1800497 was genotyped in 202 (135 female, 67 male) severely obese individuals with an initial body mass index of 41.7 ± 0.5 kg/m² who participated in a weight-loss program consisting of a weight-loss phase with a formula diet (12 wk) and a weight-maintenance phase (40 wk). Measurements were collected at baseline, after the weight-loss phase, and at the end of the weight-maintenance phase at 1 y.
RESULTS: Genotyping revealed 4 A1A1, 67 A1A2, and 131 A2A2 genotype carriers. Of the 202 subjects in the program, 66.8% completed the program and 33.2% terminated prematurely. Neither the attrition rate (P = 0.44) nor the overall weight loss was influenced by the different genotypes (P = 0.96). However, younger A1⁺ participants (A1A1 and A1A2) had a higher body mass index at all time points (baseline, P = 0.04; after weight loss, P = 0.05; after weight maintenance, P = 0.02). They also showed less overall weight loss (P = 0.05), which derived mainly from a greater weight regain during the maintenance phase (P = 0.02).
CONCLUSION: In this program, younger A1⁺ participants exhibited problems in maintaining weight loss during a weight-loss program.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22541053     DOI: 10.1016/j.nut.2011.12.018

Source DB:  PubMed          Journal:  Nutrition        ISSN: 0899-9007            Impact factor:   4.008


  16 in total

Review 1.  Hormonal and neural mechanisms of food reward, eating behaviour and obesity.

Authors:  Susan Murray; Alastair Tulloch; Mark S Gold; Nicole M Avena
Journal:  Nat Rev Endocrinol       Date:  2014-06-24       Impact factor: 43.330

2.  Genetic modulation of the serotonergic pathway: influence on weight reduction and weight maintenance.

Authors:  Dirk Wallmeier; Julia K Winkler; Thomas Fleming; Annika Woehning; Katharina Huennemeyer; Eva Roeder; Peter P Nawroth; Hans-Christoph Friederich; Christian Wolfrum; Jobst-Hendrik Schultz; Gottfried Rudofsky
Journal:  Genes Nutr       Date:  2013-06-25       Impact factor: 5.523

3.  Relation of the multilocus genetic composite reflecting high dopamine signaling capacity to future increases in BMI.

Authors:  Sonja Yokum; C Nathan Marti; Andrew Smolen; Eric Stice
Journal:  Appetite       Date:  2014-12-15       Impact factor: 3.868

4.  The effect of the ANKK1/DRD2 Taq1A polymorphism on weight changes of dopaminergic treatment in prolactinomas.

Authors:  A P Athanasoulia; C Sievers; M Uhr; M Ising; G K Stalla; H J Schneider
Journal:  Pituitary       Date:  2014-06       Impact factor: 4.107

Review 5.  DRD2: Bridging the Genome and Ingestive Behavior.

Authors:  Xue Sun; Serge Luquet; Dana M Small
Journal:  Trends Cogn Sci       Date:  2017-03-31       Impact factor: 20.229

6.  High Fat Diet Increases [3H] Flunitrazepam Binding in the Mouse Brain that is Dependent on the Expression of the Dopamine D2 Gene.

Authors:  Josh Neuman; Nicole Roeder; Brittany Richardson; Teresa Quattrin; John Hamilton; Panayotis K Thanos
Journal:  Neurochem Res       Date:  2022-06-16       Impact factor: 4.414

7.  Interaction between the obesity-risk gene FTO and the dopamine D2 receptor gene ANKK1/TaqIA on insulin sensitivity.

Authors:  Martin Heni; Stephanie Kullmann; Emma Ahlqvist; Robert Wagner; Fausto Machicao; Harald Staiger; Hans-Ulrich Häring; Peter Almgren; Leif C Groop; Dana M Small; Andreas Fritsche; Hubert Preissl
Journal:  Diabetologia       Date:  2016-09-06       Impact factor: 10.122

8.  Associations of the ANKK1 and DRD2 gene polymorphisms with overweight, obesity and hedonic hunger among women from the Northwest of Iran.

Authors:  Fereshteh Aliasghari; Saba A Nazm; Sepideh Yasari; Reza Mahdavi; Morteza Bonyadi
Journal:  Eat Weight Disord       Date:  2020-02-04       Impact factor: 4.652

9.  Impact of the DRD2 Polymorphisms on the Effectiveness of the Training Program.

Authors:  Katarzyna Świtała; Aleksandra Bojarczuk; Jacek Hajto; Marcin Piechota; Maciej Buryta; Agata Leońska-Duniec
Journal:  Int J Environ Res Public Health       Date:  2022-04-19       Impact factor: 3.390

10.  Weight-loss response to naltrexone/bupropion is modulated by the Taq1A genetic variant near DRD2 (rs1800497): A pilot study.

Authors:  Jamie A Mullally; Wendy K Chung; Charles A LeDuc; Tirissa J Reid; Gerardo Febres; Steven Holleran; Rajasekhar Ramakrishnan; Judith Korner
Journal:  Diabetes Obes Metab       Date:  2021-01-08       Impact factor: 6.408

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.